Virtus Fund Advisers, LLC Atri Cure, Inc. Transaction History
Virtus Fund Advisers, LLC
- $25 Million
- Q2 2024
A detailed history of Virtus Fund Advisers, LLC transactions in Atri Cure, Inc. stock. As of the latest transaction made, Virtus Fund Advisers, LLC holds 810 shares of ATRC stock, worth $27,143. This represents 0.07% of its overall portfolio holdings.
Number of Shares
810
Previous 752
7.71%
Holding current value
$27,143
Previous $22,000
18.18%
% of portfolio
0.07%
Previous 0.08%
Shares
2 transactions
Others Institutions Holding ATRC
# of Institutions
206Shares Held
48.3MCall Options Held
111KPut Options Held
23.8K-
Vanguard Group Inc Valley Forge, PA4.62MShares$155 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.62MShares$155 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY4.2MShares$141 Million0.03% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT2.67MShares$89.6 Million0.39% of portfolio
-
Macquarie Group LTD Australia, C32MShares$67 Million0.05% of portfolio
About AtriCure, Inc.
- Ticker ATRC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 46,424,700
- Market Cap $1.56B
- Description
- AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...